![Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX]](https://cedclinic.com/wp-content/uploads/2026/06/ced-unsplash-ke6jYtwXDKA-1-150x150.jpg "Medicinal Cannabis Draws Eyes as Oil Slides and Bond Yields Climb [FTSE AIM UK 50 INDEX] 18")
Real-world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2-q13.1 duplication and deletion syndromes: A multicenter study.
A multicenter study of CBD treatment for genetic epilepsy syndromes found meaningful seizure reduction in 64% of patients with rare 15q genetic disorders. The research provides real-world evidence supporting cannabidiol as a viable treatment option for…
Cannabidiol in Epilepsy: Restoring Locomotion and Seizure Control.
A comprehensive review demonstrates CBD's potential for seizure control while maintaining motor function in epilepsy models. This motor-sparing profile of CBD distinguishes it from traditional antiepileptics that often impair movement and coordination.…
Cannabidiol & Its Anti-Epileptic Properties: Clinical Trial Findings
This clinical trial investigates cannabidiol anti epileptic properties and its effects on cortical excitability. Results indicate CBD alone does not reduce cortical excitability or sedation. The study highlights CBD's benefits may depend on interactions…
Alabama’s 1st Medical Cannabis Dispensary Plans to Open Next Month
Alabama medical cannabis dispensary opening represents a milestone for patients with qualifying conditions. This development expands access to regulated cannabis medicine in Alabama. Patients and clinicians now have new options for treatment under the…
Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdEpilepsyPharmaceutical CannabisClinical…
Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav … – Investors
Jazz Pharmaceuticals continues pharmaceutical CBD research with new presentations on Epidiolex. These studies focus on expanding evidence-based cannabinoid medicine beyond approved epilepsy indications. Pharmaceutical CBD research informs off-label…
Medical Marijuana’s Growing Role in Clinical Trials
Medical cannabis clinical trials are increasing, marking a shift toward evidence-based cannabis medicine. This growth supports clinicians in making informed treatment decisions. The focus on rigorous trials enhances understanding of cannabis’s…
Marijuana Rescheduling Could ‘Unlock Research’ To Treat Rare Diseases, Father Of …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Rare DiseasesPediatric MedicineResearch…
Cresco Labs Joins Texas Medical Cannabis Program
Cresco Labs has been awarded a license in the Texas medical cannabis program, which restricts products to low THC levels. This expansion may improve patient access to standardized cannabis products. However, the program's narrow qualifying conditions…
5 Essential Breakthroughs in Cannabis Neuromodulation
5 Essential Breakthroughs in Cannabis Neuromodulation Imagine a world where a simple plant could revolutionize the way we treat some of the most challenging health issues, from anxiety and depression to Alzheimer's and Parkinson's disease.…